glycosidas
involv
biosynthesi
process
oligosaccharid
chain
glycoprotein
endoplasm
reticulum
er
figur
inhibit
glycosidas
especi
profound
effect
glycan
structur
consequ
affect
matur
transport
secret
function
glycoprotein
could
therefor
alter
recognit
neuraminidas
inhibitor
tamiflu
exampl
prescrib
treatment
influenza
viru
digest
inhibitor
also
call
glyset
miglitol
scheme
use
treatment
recent
studi
also
show
deoxynojirimycin
dnj
deriv
especi
dnj
potenti
use
treat
sever
human
diseas
virus
hepat
hepat
dengu
glycosphingolipid
storag
efficaci
iminocyclitol
attribut
mimicri
transit
state
enzymat
glycosid
iminocyclitol
natur
power
inhibitor
larg
rang
even
surpass
activ
dnj
frequent
use
iminocyclitol
carri
hydroxyl
group
specif
orient
mimic
shape
charg
react
sugar
moieti
transit
sinc
enzym
inhibit
could
significantli
enhanc
slight
modif
aglycon
iminocyclitol
could
use
common
core
develop
select
glycosidas
inhibitor
identif
addit
group
occupi
aglycon
space
quickli
find
group
attach
iminocyclitol
decid
conduct
combinatori
modif
compound
scheme
amin
group
microtit
plate
follow
screen
situ
strategi
success
appli
initi
screen
librari
inhibitor
panel
glycosidas
vitro
potent
inhibitor
identifi
screen
test
assay
japanes
enceph
viru
jev
dengu
viru
serotyp
well
sever
acut
respiratori
syndrom
coronaviru
addit
discov
new
potent
inhibitor
human
domin
glycosidas
releas
chrondrocyt
extracellular
compart
domin
glycosidas
synovi
fluid
patient
inhibitor
enzym
could
use
treatment
preliminari
inhibitori
assay
core
panel
glycosidas
differ
sourc
show
broad
spectrum
inhibitori
activ
except
see
support
inform
core
moder
inhibitori
activ
librari
gener
screen
studi
mixtur
iminocyclitol
carboxyl
acid
equiv
scheme
diisopropyl
ethylamin
diea
equiv
tetramethyl
uronium
hexafluorophosph
hbtu
equiv
dmso
shaken
microtit
plate
h
crude
reaction
product
randomli
select
analyz
ensur
presenc
desir
product
reaction
mixtur
dilut
appropri
buffer
solut
transfer
anoth
microtit
plate
screen
directli
without
purif
base
valu
see
support
inform
concentr
reaction
product
set
assum
amid
format
complet
percentag
inhibit
rel
control
calcul
basi
absorb
nm
releas
correspond
substrat
compound
gener
reaction
sever
inhibitor
found
see
support
inform
good
inhibitor
enzym
select
resynthes
pure
compound
reevalu
determin
k
valu
tabl
scheme
screen
baker
yeast
inhibit
reaction
product
found
potent
see
support
inform
overal
librari
inhibitori
activ
briefli
inhibit
greater
extent
compound
contain
ring
eg
heteroaromat
compon
eg
worth
note
enzym
interact
bicycl
aglycon
eg
vs
vs
bacillu
stearothermophilu
also
investig
librari
result
similar
baker
yeast
potent
one
yeast
compound
k
valu
nm
select
interestingli
valu
compound
order
magnitud
differ
result
suggest
lipophil
bind
pocket
exist
allow
bicycl
ring
indol
naphthalen
fit
specif
orient
bicycl
ring
also
import
screen
almond
reaction
product
found
compar
potent
show
weaker
effect
dimethylamino
group
attach
aromat
ring
could
enhanc
inhibitori
activ
eg
document
particular
structur
moieti
shown
significantli
inhibit
enzym
especi
substitu
eg
moieti
board
rang
biolog
properti
includ
find
suggest
new
applic
acid
deriv
inhibitori
reaction
product
inhibit
k
valu
gener
deriv
select
inhibitor
inhibit
jack
bean
seem
greater
hydrophil
substitu
posit
eg
howev
none
substitu
potent
acetamido
group
indic
crucial
role
enzym
activ
site
studi
also
show
potent
inhibitor
found
deriv
though
rel
weaker
inhibitor
observ
overal
combinatori
synthesi
follow
rapid
screen
situ
describ
provid
platform
identifi
select
glycosidas
inhibitor
modif
common
core
aglycon
side
chain
endoplasm
reticulum
er
inhibitor
block
trim
step
glycosyl
shown
elimin
product
sever
previous
report
antiviru
effect
dnj
flaviviru
howev
iminocyclitol
test
antivir
activ
potent
inhibitor
hand
test
potenti
antivir
effect
base
previou
assay
system
jev
detail
antiviru
assay
given
experiment
section
compound
exhibit
inhibit
data
shown
peracetyl
compound
believ
increas
cellular
uptak
convert
compound
cellular
subject
cell
assay
howev
also
show
inhibit
data
shown
turn
attent
modifi
ring
nitrogen
potent
inhibitor
modif
alkyl
dnj
previous
report
enhanc
abil
inhibit
glycan
process
viru
studi
influenc
length
assay
seri
compound
alkyl
chain
rang
attach
compound
synthes
use
reduct
amin
appropri
aldehyd
give
rise
compound
scheme
inhibit
activ
deriv
also
investig
see
support
inform
result
show
molecul
still
select
albeit
low
activ
compar
parent
compound
result
also
observ
vitro
activ
dnj
sodium
phennylamino
carbonyl
benzen
sulfon
acid
hydrat
xtt
assay
measur
cell
prolifer
indic
compound
toxic
figur
except
compound
show
low
level
cytotox
gener
alkyl
iminocylitol
activ
jev
infect
figur
b
rel
viru
titer
deriv
cell
treat
newli
synthes
molecul
less
potent
infect
figur
c
howev
infect
compound
potent
compound
figur
appear
less
cytotox
potent
tabl
present
studi
compound
chain
length
nine
ten
twelv
carbon
respect
found
optim
antivir
activ
similar
effect
also
notic
varicella
zoster
longer
alkyl
chain
decyl
chain
compound
provid
modest
increas
potenc
assay
also
result
increas
cytotox
presum
due
disrupt
lipid
structur
perspect
alkyl
iminocyclitol
view
consist
two
distinct
molecular
element
imino
sugar
head
group
side
chain
head
group
recogn
role
tail
shown
unclear
might
abl
insert
membran
increas
local
concentr
near
er
recent
studi
iminocyclitol
found
still
activ
although
lack
abil
inhibit
observ
suggest
might
possess
differ
antivir
mechan
nevertheless
found
inhibit
either
jev
assay
weaker
inhibitor
deriv
core
eight
ten
carbon
scheme
evalu
found
inhibit
either
jev
infect
data
shown
assay
inhibitor
also
screen
infect
follow
previous
establish
compound
around
antivir
effect
compound
jev
shown
present
studi
like
mediat
inhibit
er
howev
possibl
mechan
besid
inhibit
rigor
previou
studi
compound
deriv
acetamidomethyl
hydroxymethyl
pyrrolidin
found
potent
inhibitor
human
k
particular
incub
human
chondrosarcoma
cell
iminocyclitol
result
accumul
glycosaminoglycan
gag
fraction
decreas
releas
gag
cultur
supernat
discoveri
iminocyclitol
potenti
chondroprotect
agent
suggest
new
avenu
develop
drug
treat
osteoarthr
order
improv
potenc
consider
effort
direct
toward
modif
ring
nitrogen
nitrogen
iminocyclitol
howev
none
synthes
inhibitor
potent
compound
relationship
iminocyclitol
reveal
acetamido
group
posit
crucial
activ
site
pocket
toler
larger
substitu
methyl
group
ring
nitrogen
enhanc
inhibit
activ
wherea
aromat
ring
substitu
caus
decreas
inhibit
activ
altern
approach
increas
potenc
probe
distant
site
therefor
decid
attach
alkyl
group
termin
amin
ring
nitrogen
reduct
anim
result
primari
amin
easi
diversifi
format
gener
librari
mention
strategi
began
reduct
amin
compound
aldehyd
differ
length
give
compound
scheme
intermedi
either
deprotect
acid
condit
hydrogenolyz
give
primari
amin
first
attempt
gener
librari
compound
format
mention
screen
show
compound
significantli
enhanc
inhibitori
activ
data
shown
thu
inhibit
studi
compound
human
placenta
carri
use
substrat
appar
k
v
max
valu
substrat
calcul
doubl
reciproc
plot
k
valu
determin
replot
k
app
versu
inhibitor
concentr
compound
potent
competit
inhibitor
k
valu
nm
figur
interestingli
vari
linkag
compound
observ
trend
human
inhibit
compound
heptamin
moieti
strongest
inhibitor
attempt
optim
inhibitor
linker
replac
ethylen
glycol
chain
hydrophil
linker
give
compound
k
nm
moder
chain
give
compound
k
nm
respect
howev
modif
neg
effect
indic
import
role
amino
group
lipophil
chain
compound
crystal
structur
human
b
complex
model
reveal
narrow
hydrophob
cleft
activ
site
mainli
enclos
group
residu
backbon
residu
figur
amino
group
termin
site
expect
larg
proton
bind
enzym
presum
form
salt
bridg
secondari
aglycon
bind
site
appear
alkyl
linkag
long
enough
bring
amin
end
near
enough
interact
backbon
carbonyl
possibl
ionic
interact
carboxyl
group
base
structur
appli
combinatori
synthesi
microtit
plate
situ
screen
method
power
procedur
rapidli
identifi
signific
differ
among
similar
enzym
develop
potent
select
inhibitor
inhibitor
structur
bicycl
ring
indol
naphthalen
gave
best
inhibitori
potenc
illustr
k
valu
nm
increas
activ
compar
parent
core
deriv
compound
also
test
antivir
activ
contain
lipophil
alkyl
group
activ
jev
infect
given
import
role
osteoarthr
inhibit
investig
regard
substitu
effect
nitrogen
ring
nitrogen
core
result
show
acetamido
group
posit
crucial
modif
ring
nitrogen
aromat
group
caus
loss
inhibit
howev
extend
alkyl
chain
ring
nitrogen
gave
potent
human
inhibitor
known
date
compound
k
valu
nm
model
indic
strong
bind
compound
lipophil
cleft
ionic
interact
secondari
bind
site
altogeth
work
clearli
demonstr
effect
simpl
combinatori
approach
strategi
rapid
discoveri
potent
inhibitor
potenti
candid
medic
applic
materi
sourc
enzym
follow
ec
baker
yeast
bacillu
stearothermophilu
ec
almond
ec
aspergillu
niger
ec
jack
bean
ec
snail
aceton
powder
ec
jack
bean
human
placenta
enzym
purchas
sigma
st
loui
mo
sweet
almond
ec
escherichia
coli
purchas
toyobo
co
ltd
osaka
japan
human
ec
recombin
protein
gift
professor
lin
academia
sinica
taipei
taiwan
gener
method
chemic
synthesi
nonaqu
reaction
run
glasswar
nitrogen
atmospher
reaction
monitor
chromatographi
merck
silica
gel
util
ninhydrin
cerium
molybd
stain
reagent
silica
gel
use
flash
column
chromatographi
mallinckrodt
type
mesh
unless
otherwis
note
reagent
materi
obtain
commerci
sourc
use
provid
without
purif
nmr
spectra
record
bruker
spectromet
referenc
residu
solvent
peak
meoh
gener
procedur
coupl
reaction
situ
screen
carboxyl
acid
mm
stock
solut
dmso
hbtu
mm
stock
solut
dmso
equiv
diea
mm
stock
solut
dmso
equiv
ad
dmso
well
microtit
plate
reaction
initi
ad
compound
mm
stock
solut
well
reaction
mixtur
shaken
room
temperatur
h
monitor
complet
base
disappear
tlc
mobil
phase
r
aliquot
withdrawn
previou
reaction
mixtur
mix
phosphat
buffer
ph
reach
dilut
procedur
repeat
give
desir
dilut
ie
final
concentr
product
well
microtit
plate
well
anoth
plate
baker
yeast
u
mm
mix
aliquot
aforement
mixtur
buffer
give
inhibitor
enzym
inhibit
assay
enzym
assay
gener
procedur
assay
variou
glycosidas
initi
veloc
hydrolysi
measur
spectrophotometr
variou
concentr
mm
mm
mm
mm
mm
mm
mm
nm
use
bio
assay
reader
ht
plu
obtain
data
fit
equat
use
kaleida
graph
program
determin
appar
k
valu
substrat
concentr
use
fivefold
k
valu
evalu
inhibitori
effect
variou
glycosidas
give
ideal
progress
curv
appropri
enzym
concentr
unit
per
ml
inhibitor
concentr
nm
use
inhibitori
concentr
determin
concentr
veloc
hydrolysi
reduc
compar
untreat
control
assay
perform
well
microtit
plate
contain
either
sodium
phosphat
buffer
mm
ph
mcilvain
buffer
mm
ph
jack
bean
k
valu
inhibitor
determin
doubl
reciproc
plot
vs
give
appar
k
k
presenc
inhibitor
secondari
plot
gener
plot
appar
k
valu
function
inhibitor
concentr
k
calcul
neg
valu
plot
kinet
analysi
human
placenta
incub
perform
total
volum
unless
otherwis
state
reaction
mixtur
contain
citrat
buffer
mm
ph
variou
amount
variou
amount
inhibitor
mu
per
well
incub
min
reaction
termin
addit
sodium
glycin
buffer
ph
enzym
activ
measur
releas
excit
wavelength
nm
emiss
wavelength
nm
cell
line
virus
viru
infect
cell
cultur
rpmi
medium
contain
fetal
bovin
serum
fb
mm
jev
strain
taiwanes
strain
use
studi
viru
propag
carri
cell
use
rpmi
medium
contain
fb
inhibitor
dissolv
dmso
infect
jev
monolay
cell
plate
adsorb
viru
h
adsorpt
unbound
virus
remov
gentl
wash
medium
follow
addit
fresh
medium
contain
variou
amount
inhibitor
incub
determin
viru
titer
cultur
media
harvest
assay
variou
viru
dilut
ad
confluent
cell
incub
h
adsorpt
cell
wash
overlaid
agaros
seaplaqu
fmc
bioproduct
cambrix
bioscienc
rockland
usa
contain
rpmi
fb
incub
day
jev
day
cell
fix
formaldehyd
stain
crystal
violet
inhibitor
concentr
requir
inhibit
viru
product
determin
indirect
immunofluoresc
assay
ifa
cell
fix
acetonemethanol
min
treat
monoclon
antibodi
mab
jev
wash
salin
pb
cell
stain
goat
fluorescein
isothiocyan
fitc
secondari
antibodi
jackson
immunoresearch
west
grove
pa
usa
result
cell
examin
leica
fluoresc
microscop
viral
protein
express
ifa
read
fluoresc
micropl
reader
molecular
devic
excit
wavelength
nm
emiss
wavelength
nm
data
shown
percentag
infect
cell
versu
without
inhibitor
treatment
none
cell
nuclei
visual
dapi
stain
sodium
chlorid
room
temperatur
min
xtt
assay
determin
cell
viabil
colorimetr
assay
perform
cell
prolifer
kit
ii
roch
cell
plate
incub
variou
concentr
inhibitor
day
xtt
label
reagent
ad
cultur
medium
cell
incub
min
read
elisa
reader
nm
molecular
devic
primari
screen
activ
vero
cell
per
well
cultur
plate
dulbecco
modifi
eagl
medium
dmem
supplement
fb
cultur
medium
remov
day
incub
cell
reach
confluenc
solut
dmem
fb
contain
compound
test
place
three
well
cell
incub
incub
h
inocul
hk
strain
dose
per
well
cytopath
morpholog
cell
examin
use
invert
microscop
h
infect
comput
model
dock
experi
conduct
use
autodock
lamarckian
genet
algorithm
lga
crystal
structur
human
b
complex
inhibitor
download
rcsb
protein
data
bank
pdb
code
chain
structur
extract
util
dock
simul
structur
model
inhibitor
built
cach
fujitsu
japan
refin
perform
optim
geometri
calcul
mechan
use
augment
paramet
store
pdb
format
mgltool
molecular
graphic
lab
scripp
research
institut
use
prepar
paramet
creation
meet
input
requir
autodock
briefli
essenti
hydrogen
atom
ad
structur
model
hexosaminidas
follow
assign
kollman
unit
atom
charg
solvat
paramet
compound
molecul
assign
charg
nonpolar
h
atom
merg
torsion
defin
autogrid
tool
autodock
appli
produc
energi
grid
xyz
direct
space
variou
type
compound
atom
grip
map
center
activ
site
bound
dock
experi
compound
kept
flexibl
protein
kept
rigid
soli
wet
local
search
method
lga
appli
gener
avail
conform
compound
structur
within
activ
site
conform
search
conduct
util
quaternion
torsion
step
compound
structur
maximum
energi
unit
evalu
pose
select
gener
per
run
plausibl
dock
mode
select
abund
cluster
strongest
affin
energi
pictur
final
simul
complex
gener
mgltool
